Development of a biocompatible CuO-ZnO nanocomposite for targeting of Chloramphenicol with enhanced antibacterial and anti-biofilm efficacy.

The extensive use and adverse side effects of standard antibiotics have imposed challenges for therapeutic treatment. Multi-drug resistant (MDR) pathogens need much higher concentrations of antimicrobial drugs, which kill the beneficial microflora of…

Preview only. Read the full abstract at the source